Drug Type Biological products |
Synonyms- |
Target- |
Action- |
Mechanism- |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPhase 1/2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Chronic graft-versus-host disease | Phase 2 | United States | 20 Dec 2019 |
Phase 2 | 15 | (Processed Amniotic Fluid (pAF)) | jxnulfvitv(odrjczzqfk) = lkhvjoqdbx aljdlfvfhi (flycbzjqtv ) | Positive | 10 Dec 2023 | ||
(Saline treatment (placebo)) | jxnulfvitv(odrjczzqfk) = sfbcgqjibk aljdlfvfhi (flycbzjqtv ) |